The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

Study results show that patients with chronic obstructive pulmonary disease (COPD) and comorbid asthma may have a greater risk of hospitalization from COVID-19 if they use bronchodilators or steroids ...

If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist ...

UK's health regulator on Monday approved GSK's twice-yearly drug for use as an add-on treatment for asthma in patients aged ...

This new data was the result of a recent case-controlled study that aimed to assess the effects of a PDL that provides an exemption from out-of-pocket cost sharing for patients’ asthma medications on ...

Sandoz Group Ltd ($SDZXF) announced an update on their ongoing clinical study. Study Overview: Sandoz Group Ltd is conducting a clinical study ...

Are you one of those families racing to find new asthma medications as respiratory virus season approaches? The Massachusetts Department of Public Health is trying to help patients and families access ...

Editor's note: Dr. Edith Bracho-Sanchez is a primary care pediatrician, director of pediatric telemedicine and assistant professor of pediatrics at Columbia University Irving Medical Center. Flovent, ...

How does the switch to a high-deductible health plan affect children with asthma? A new study suggests that enrollment in a high-deductible health plan (HDHP) may not be associated with changes in ...

Despite a declining trend, the number of adults in the U.S. who say they did not adhere to their asthma treatment because of costs remains high, according to an observational study. From 2011-2022, ...

Please provide your email address to receive an email when new articles are posted on . In 2011, 23.2% of adults with asthma experienced cost-related medication nonadherence vs. 13.1% in 2022. The ...